- Home
- FAMI vs KTTA Comparison
FAMI vs KTTA Comparison
Compare FAMI & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FAMI
- KTTA
- Stock Information
- Founded
- FAMI 2015
- KTTA 2020
- Country
- FAMI China
- KTTA United States
- Employees
- FAMI N/A
- KTTA N/A
- Industry
- FAMI Packaged Foods
- KTTA Biotechnology: Pharmaceutical Preparations
- Sector
- FAMI Consumer Staples
- KTTA Health Care
- Exchange
- FAMI Nasdaq
- KTTA Nasdaq
- Market Cap
- FAMI 3.1M
- KTTA 3.2M
- IPO Year
- FAMI 2018
- KTTA 2021
- Fundamental
- Price
- FAMI $0.32
- KTTA $2.73
- Analyst Decision
- FAMI
- KTTA
- Analyst Count
- FAMI 0
- KTTA 0
- Target Price
- FAMI N/A
- KTTA N/A
- AVG Volume (30 Days)
- FAMI 300.7K
- KTTA 23.4K
- Earning Date
- FAMI 01-27-2025
- KTTA 11-13-2024
- Dividend Yield
- FAMI N/A
- KTTA N/A
- EPS Growth
- FAMI N/A
- KTTA N/A
- EPS
- FAMI 0.13
- KTTA N/A
- Revenue
- FAMI $86,261,500.00
- KTTA N/A
- Revenue This Year
- FAMI N/A
- KTTA N/A
- Revenue Next Year
- FAMI N/A
- KTTA N/A
- P/E Ratio
- FAMI $2.44
- KTTA N/A
- Revenue Growth
- FAMI N/A
- KTTA N/A
- 52 Week Low
- FAMI $0.17
- KTTA $2.37
- 52 Week High
- FAMI $2.35
- KTTA $9.25
- Technical
- Relative Strength Index (RSI)
- FAMI 57.12
- KTTA 43.12
- Support Level
- FAMI $0.27
- KTTA $2.37
- Resistance Level
- FAMI $0.33
- KTTA $2.98
- Average True Range (ATR)
- FAMI 0.03
- KTTA 0.23
- MACD
- FAMI 0.00
- KTTA 0.04
- Stochastic Oscillator
- FAMI 79.14
- KTTA 51.80
About FAMI Farmmi Inc.
Farmmi Inc is a supplier of agricultural products. The products of the company are Shiitake Mushroom, Mu Er Mushroom and other edible fungi and other agricultural products. The majority of products are sold in mainland China.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia.